Bushen Yijing Decoction (BSYJ) exerts an anti-systemic sclerosis effect via regulating MicroRNA-26a /FLI1 axis

References

• Fett N. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):432–437.
   PubMed Web of Science ®Google Scholar
• Gilbane AJ, Denton CP, Holmes AM. Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res Ther. 2013;15(3):215.
   PubMed Web of Science ®Google Scholar
• Denton CP, Black CM, Abraham DJ. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol. 2006;2(3):134.
   PubMedGoogle Scholar
• Asano Y, Stawski L, Hant F, et al. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol. 2010;176(4):1983–1998.
   PubMed Web of Science ®Google Scholar
• Wang Y, Fan PS, Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum. 2006;54(7):2271–2279.
   PubMedGoogle Scholar
• Qi Q, Mao Y, Yi J. Effect of Bushen Yijing Formula on dermal fibrosis in scleroderma model mice. J New Chin Med. 2012;6:149–151.
   Google Scholar
• Qi Q, Mao Y, Yi J. Research on Bushen Yijing Therapy to the balance of SMAD3/FLI1 in fibroblast of scleroderma. J Sichuan Trad Chin Med. 2012;30(6):43–44.
   Google Scholar
• Qiu LP, Tian YZ, Zhang JL, et al. Effects of Bushen Yijing therapy on endothelial to mesenchymal transition in systemic scleroderma. J Shanghai Univ Trad Chin Med. 2017;31(1):63–68.
   Google Scholar
• Han J, Denf W, Xie S. Effect of tonifying kidney and strengthening essence methods on endothelial-mesenchymal transition scleroderma mice based on regulation of Fli1. Global Trad Chin Med. 2018;11(10):19–24.
   Google Scholar
• Tong PD, Wang ML, Hu X, et al. Effect of retarding aging Chinese drug Bushen Yijing Decoction on rat left ventricular myosin heavy chain(MHC) mRNA Change with aging. Chin J Basic Med Tradit Chin Med. 2001;7(4):34–36.
   Google Scholar
• Zhang G, Ma J, Zhang Q. [Experimental study on effect of Bushen Yijing recipe in delaying senility of bone and brain of aged male rats]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2000;20(1):43–45.
   PubMedGoogle Scholar
• Zhu TY, Shi YY, Zhang G. Experimental study of reinforcing effect of Bushen Yijing capsule on bone quality of cancellous bone in ovariectomy caused rats osteoporosis model. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2001;21(9):688–691.
   PubMedGoogle Scholar
• Kim DH, Saetrom P, Snove SO, et al. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A. 2008;105(42):16230–16235.
   PubMed Web of Science ®Google Scholar
• Saj A, Lai EC. Control of microRNA biogenesis and transcription by cell signaling pathways. Curr Opin Genet Dev. 2011;21(4):504–510.
   PubMed Web of Science ®Google Scholar
• O’Reilly S. MicroRNAs in fibrosis: opportunities and challenges. Arthritis Res Ther. 2016;18(1):11.
   PubMedGoogle Scholar
• Henderson J, Distler J, O’Reilly S. The role of epigenetic modifications in systemic sclerosis: a druggable target. Trends Mol Med. 2019;25(5):395–411.
   PubMed Web of Science ®Google Scholar
• Zhu H, Li Y, Qu S, et al. MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma. J Clin Immunol. 2012;32(3):514–522.
   PubMed Web of Science ®Google Scholar
• Etoh M, Jinnin M, Makino K, et al. MicroRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma. Arch Dermatol Res. 2013;305(1):9–15.
   PubMed Web of Science ®Google Scholar
• Zhu H, Luo H, Li Y, et al. MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression. J Clin Immunol. 2013;33(6):1143–1144.
   Web of Science ®Google Scholar
• Makino T, Jinnin M, Etoh M, et al. Down-regulation of microRNA-196a in the sera and involved skin of localized scleroderma patients. Eur J Dermatol. 2014;24(4):470–476.
   PubMed Web of Science ®Google Scholar
• Liang H, Xu C, Pan Z, et al. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Mol Ther. 2014;22(6):1122–1133.
   PubMed Web of Science ®Google Scholar
• Wei C, Kim IK, Kumar S, et al. NF-κB mediated miR-26a regulation in cardiac fibrosis. J Cell Physiol. 2013;228(7):1433–1442.
   PubMed Web of Science ®Google Scholar
• Su N, Qian M, Deng M. Integrative approaches for microRNA target prediction: combining sequence information and the paired mRNA and miRNA expression profiles. Curr Bioinform. 2013;8(1):37–45.
   PubMed Web of Science ®Google Scholar
• Balbir-Gurman A, Braun-Moscovici Y. Scleroderma - new aspects in pathogenesis and treatment. Best Pract Res Clin Rheumatol. 2012;26(1):13–24.
   PubMed Web of Science ®Google Scholar
• Ponticos M, Papaioannou I, Xu S, et al. The failure to degrade JunB contributes to Collagen type I over-production and dermal fibrosis in Scleroderma. Arthritis Rheumatol. 2014;67(1):243–253.
   Google Scholar
• Czuwaraladykowska J, Shirasaki F, Jackers P, et al. Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem. 2001;276(24):20839–20848.
   PubMed Web of Science ®Google Scholar
• Noda S, Asano Y, Nishimura S, et al. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nat Commun. 2014;5(6):5797.
   PubMedGoogle Scholar
• Larsson E, Fuchs PF, Heldin J, et al. Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med. 2009;1(11):108.
   PubMedGoogle Scholar
• Liu H, Song L, Huang W. MiR26a and miR939 regulate the replication of H1N1 influenza virus in MDCK cell. Wei Sheng Wu Xue Bao. 2010;50(10):1399–1405.
   PubMedGoogle Scholar
• Sekimoto N, Suzuki A, Suzuki Y, et al. Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells. Mol Med Rep. 2017;15(2):534–542.
   PubMed Web of Science ®Google Scholar
• Zhang R, Tian A, Wang J, et al. MiR26a modulates Th17/T reg balance in the EAE model of multiple sclerosis by targeting IL6. Neuromol Med. 2015;17(1):24–34.
   PubMed Web of Science ®Google Scholar
• Kota J, Chivukula RR, O’Donnell KA, et al. Therapeutic delivery of miR-26a inhibits cancer cell proliferation and induces tumor-specific apoptosis. Cell. 2009;137(6):1005.
   PubMed Web of Science ®Google Scholar
• Lu J, He M, Wang L, et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res. 2011;71(1):225–233.
   PubMed Web of Science ®Google Scholar
• Luzi E, Marini F, Sala SC, et al. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res. 2010;23(2):287–295.
   Web of Science ®Google Scholar
• Liu B, Wu X, Liu B, et al. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta. 2012;1822(11):1692–1704.
   PubMed Web of Science ®Google Scholar
• Wang D. Discrepancy between mRNA and protein abundance: insight from information retrieval process in computers. Comput Biol Chem. 2008;32(6):462–468.
   PubMed Web of Science ®Google Scholar
• Kinsella MB, Smith EA, Miller KS, et al. Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma. Arthritis Rheum. 2014;32(5):577–583.
   Google Scholar
• Che X, Wang Q, Xie Y, et al. Astragaloside IV suppresses transforming growth factor-β1 induced fibrosis of cultured mouse renal fibroblasts via inhibition of the MAPK and NF-κB signaling pathways. Biochem Biophys Res Commun. 2015;464(4):1260–1266.
   PubMed Web of Science ®Google Scholar
• Qian W, Cai X, Qian Q, et al. Astragaloside IV modulates TGF‐β1‐dependent epithelial‐mesenchymal transition in bleomycin‐induced pulmonary fibrosis. J Cell Molr Med. 2018;22(9):4354–4365.
   PubMed Web of Science ®Google Scholar
• Wang CY, Liu Q, Huang QX, et al. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress. Phytomedicine. 2013;20(7):592–599.
   PubMed Web of Science ®Google Scholar